logo
Select company
Select metric
$ -1.09EBITDA per Share
VS
Market
17
Sector
45
Industry
60
History
78
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information

Ticker

CARM

Company Name

CARISMA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARISMA THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CARM - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -45.68M$ -1.09141.79M
3/31/2025$ -44.47M$ -1.06141.77M
12/31/2024$ -52.16M$ -1.26141.46M
9/30/2024$ -55.99M$ -1.35141.59M
6/30/2024$ -65.3M$ -1.57141.54M
3/31/2024$ -75.98M$ -1.86140.94M
12/31/2023$ -80.55M$ -2.4133.52M
9/30/2023$ -67.76M$ -1.68140.29M
6/30/2023$ -27.05M$ -0.67140.26M
3/31/2023$ -43.99M$ -3.44112.78M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -6.73.
  • Over the past 5 years, CARISMA THERAPEUTICS INC's average EBITDAPS has been $ -2.7.
  • The median EBITDAPS for CARISMA THERAPEUTICS INC during this period was $ -1.63
  • CARISMA THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 4.59.
  • The lowest EBITDAPS recorded by CARISMA THERAPEUTICS INC in the same timeframe $ -14.98

CARISMA THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
CSCIF : COSCIENS BIOPHARMA INC $ -5.12BOLT : BOLT BIOTHERAPEUTICS INC $ -24.58JAGX : JAGUAR HEALTH INC $ -38.13VSEE : VSEE HEALTH INC $ -5.65TRAW : TRAWS PHARMA INC $ 15.1CRIS : CURIS INC $ -2.97MRKR : MARKER THERAPEUTICS INC $ -1.04LGVN : LONGEVERON INC $ -1.16CYCN : CYCLERION THERAPEUTICS INC $ -0.63LYRA : LYRA THERAPEUTICS INC $ -28.45

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CARISMA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -39.66M ] / (Shares WA [ 5.89M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -6.73 ]

CARM - EBITDA per Share, Last 5 years

$ -14.98

Minimum

Mar 31, 2021

$ 4.59

Maximum

Mar 31, 2022

$ -2.7

Average

$ -1.63

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.02 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.02
median$ 0.99
std$ 4.26